Literature DB >> 27696217

Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

S Stevens Negus1, Matthew L Banks2.   

Abstract

Many cathinone analogs act as substrates or inhibitors at dopamine, norepinephrine, and serotonin transporters (DAT, NET, SERT, respectively). Drug selectivity at DAT vs. SERT is a key determinant of abuse potential for monoamine transporter substrates and inhibitors, such that potency at DAT > SERT is associated with high abuse potential, whereas potency at DAT < SERT is associated with low abuse potential. Quantitative structure-activity relationship (QSAR) studies with a series of 4-substituted methcathinone analogs identified volume of the 4-position substituent on the methcathinone phenyl ring as one structural determinant of both DAT vs. SERT selectivity and abuse-related behavioral effects in an intracranial self-stimulation procedure in rats. Subsequent modeling studies implicated specific amino acids in DAT and SERT that might interact with 4-substituent volume to determine effects produced by this series of cathinone analogs. These studies illustrate use of QSAR analysis to investigate pharmacology of cathinones and function of monoamine transporters.

Entities:  

Keywords:  Dopamine transporter; Flephedrone; Intracranial self-stimulation; Mephedrone; Methcathinone; Methedrone; Microdialysis; Serotonin transporter; Structure–activity relationship

Mesh:

Substances:

Year:  2017        PMID: 27696217      PMCID: PMC5425248          DOI: 10.1007/7854_2016_18

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  27 in total

Review 1.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

Authors:  Louis J De Felice; Richard A Glennon; Sidney S Negus
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

2.  Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.

Authors:  Ryan A Gregg; Michael H Baumann; John S Partilla; Julie S Bonano; Alexandre Vouga; Christopher S Tallarida; Venkata Velvadapu; Garry R Smith; M Melissa Peet; Allen B Reitz; S Stevens Negus; Scott M Rawls
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.

Authors:  S Wee; K G Anderson; M H Baumann; R B Rothman; B E Blough; W L Woolverton
Journal:  J Pharmacol Exp Ther       Date:  2005-01-26       Impact factor: 4.030

5.  Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.

Authors:  Michael H Baumann; Robert D Clark; Richard B Rothman
Journal:  Pharmacol Biochem Behav       Date:  2008-03-04       Impact factor: 3.533

6.  3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.

Authors:  Vincent Setola; Sandra J Hufeisen; K Jane Grande-Allen; Ivan Vesely; Richard A Glennon; Bruce Blough; Richard B Rothman; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

7.  A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine.

Authors:  C E Johanson; C R Schuster
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

8.  Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.

Authors:  Julie A Suyama; Farhana Sakloth; Renata Kolanos; Richard A Glennon; Matthew F Lazenka; S Stevens Negus; Matthew L Banks
Journal:  J Pharmacol Exp Ther       Date:  2015-10-15       Impact factor: 4.030

9.  Structure-activity studies on amphetamine analogs using drug discrimination methodology.

Authors:  R A Glennon; R Young; A E Hauck; J D McKenney
Journal:  Pharmacol Biochem Behav       Date:  1984-12       Impact factor: 3.533

Review 10.  Amphetamines, new psychoactive drugs and the monoamine transporter cycle.

Authors:  Harald H Sitte; Michael Freissmuth
Journal:  Trends Pharmacol Sci       Date:  2014-12-23       Impact factor: 14.819

View more
  12 in total

1.  Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Authors:  Amy R Johnson; Matthew L Banks; Dana E Selley; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

2.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

3.  Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Drug Alcohol Depend       Date:  2019-04-06       Impact factor: 4.492

4.  Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.

Authors:  Miaojun Lai; Dan Fu; Zeming Xu; Han Du; Huifen Liu; Youmei Wang; Peng Xu; Wenhua Zhou
Journal:  Psychopharmacology (Berl)       Date:  2022-06-18       Impact factor: 4.415

5.  Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Authors:  Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-02-12       Impact factor: 3.533

6.  Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.

Authors:  Mehrak Javadi-Paydar; Jacques D Nguyen; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Neuropharmacology       Date:  2017-09-04       Impact factor: 5.250

7.  The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Authors:  Brenda M Gannon; Michael H Baumann; Donna Walther; Cristian Jimenez-Morigosa; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropsychopharmacology       Date:  2018-09-10       Impact factor: 7.853

Review 8.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

9.  Neuropharmacology of Synthetic Cathinones.

Authors:  Michael H Baumann; Hailey M Walters; Marco Niello; Harald H Sitte
Journal:  Handb Exp Pharmacol       Date:  2018

Review 10.  Psychoactive Drugs-From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review.

Authors:  George Jîtcă; Bianca E Ősz; Amelia Tero-Vescan; Camil E Vari
Journal:  Antioxidants (Basel)       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.